J B Chemicals & Pharmaceuticals Ltd share price logo

J B Chemicals & Pharmaceuticals Ltd

NSE: JBCHEPHARM

BSE: 506943

Mid Cap

Pharma Sector

2435.50

-9.00

(-0.37%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

J B Chemicals & Pharmaceuticals Stock Performance

as on July 10, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹2,386.80
    ₹2,444.80
    downward going graph

    2.00%

    Downside

    0.38%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹1,603.50
    ₹2,467.70
    downward going graph

    34.16%

    Downside

    1.32%

    Upside

    downward going graph

J B Chemicals & Pharmaceuticals share price movements today

Previous Close
₹2,444.50
Open
₹2,440.00
Volume
4.12L
Upper Circuit
₹2,933.40
Lower Circuit
₹1,955.60
Day's Low - High
₹2,386.80 - ₹2,444.80
52 Week Low - High
₹1,603.50 - ₹2,467.70

J B Chemicals & Pharmaceuticals Historical Returns

1 Month Return
+ 11.04 %
3 Month Return
+ 21.9 %
1 Year Return
+ 51.42 %
3 Year Return
+ 109.03 %
5 Year Return
+ 166.73 %

J B Chemicals & Pharmaceuticals Fundamentals

as on July 10, 2026 at 4:01 pm IST

Market Cap

₹39,248.58 Cr

Return on Equity (ROE)

18.18

PE Ratio (TTM)

52.81

Return on capital employed (ROCE)

24.24

Industry PE ratio

50.84

Beta (LTM)

0

P/B Ratio

8.2

Dividend Yield

1.07

PEG Ratio

18.79

Quarterly Earnings Growth YOY

-30.42

EPS (TTM)

44.19

Book Value

259.05

J B Chemicals & Pharmaceuticals Stock Valuation

as on July 10, 2026 at 4:01 pm IST

J B Chemicals & Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (10.61x)

October 24, 2019

Industry (50.84x)

July 6, 2026

Today (52.81x)

July 6, 2026

Highest (62.92x)

February 7, 2024

LowHigh

Today’s Price to Earnings Ratio: 52.81x

J B Chemicals & Pharmaceuticals Technical Analysis

Track how J B Chemicals & Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish5
Bullish8
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
0.31
Bearish
CCI (20)
-484.59
Bullish
RSI (14)
49.85
Neutral
Momentum (10)
-3.4
Bullish
ADI (14)
29.52
Bearish
Ultimate Oscillator (7,14,28)
69.96
Neutral

Moving Averages

Name

Value

Action

SMA (20)
2435.09
Bearish
EMA (20)
2434.31
Bearish
VWMA (20)
2434.81
Bearish
SMA (50)
2432.78
Bullish
EMA (50)
2431.94
Bullish
SMA (200)
2425.07
Bullish
EMA (200)
2427.45
Bullish
KAMA (200)
2433.38
Bullish
DEMA (200)
2426.55
Bullish

J B Chemicals & Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of J B Chemicals & Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY39,248.5833.35%0.507094,147
HOLD16,838.69-1.33%0.682641,197
BUY15,439.366.08%0.008367,234
BUY9,007.752.66%1.88-34371
BUY15,047.1045.82%0.672811,703

Market expectation of J B Chemicals & Pharmaceuticals Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

57.14%

Buy

42.86%

Hold

0.00%

Sell

J B Chemicals & Pharmaceuticals Stock’s Investor Sentiment and Interest

Search interest for J B Chemicals & Pharmaceuticals Ltd Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:9% versus previous 30 day period

J B Chemicals & Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
881.74
844.51
861.73
1,004.4
1,000.62
963.49
949.48
1,093.94
1,084.9
1,064.72
904.23
Other Income
7.66
7.35
16.63
5.89
9.95
8
14.48
14.55
15.34
18.28
11.98
Total Income
889.4
851.86
878.36
1,010.29
1,010.57
971.49
963.96
1,108.49
1,100.24
1,083
916.21
Expenses
638.2
621.39
663.61
724.03
730.1
708.98
723.04
793.07
775.3
768.9
730.28
Operating Profit
243.54
223.12
198.12
280.37
270.52
254.51
226.44
300.87
309.6
295.82
173.95
Operating Profit Margin %
27.62%
26.42%
22.99%
27.91%
27.04%
26.42%
23.85%
27.5%
28.54%
27.78%
19.24%
Profit Before Interest, Tax and Depreciation
251.2
230.47
214.75
286.26
280.47
262.51
240.92
315.42
324.94
314.1
185.93
Interest
10.37
12.49
9.41
5.64
2.06
2.58
1.45
1.11
1.35
1.88
1.23
Depreciation
32.17
34.03
40.74
40.78
41.88
41.94
46.44
42.7
44.44
45.35
50.01
Profit Before Tax
208.66
183.95
164.6
239.84
236.53
217.99
193.03
271.61
279.15
266.87
134.69
Tax Paid
58.07
50.38
38.44
63.01
61.96
55.5
47.34
69.23
71.33
68.98
33.32
Profit After Tax
150.59
133.57
126.16
176.83
174.57
162.49
145.69
202.38
207.82
197.89
101.37
Total Net profit including share of profit / Loss from associate company
150.59
133.57
126.16
176.83
174.57
162.49
145.69
202.38
207.82
197.89
101.37
EPS
9.72
8.62
8.22
11.39
11.24
10.46
9.36
12.99
13.29
12.63
6.35
Actual EPS
9.72
8.62
8.22
11.39
11.24
10.46
9.36
12.99
13.29
12.63
6.35
Adjusted EPS
9.72
8.62
8.22
11.39
11.24
10.46
9.36
12.99
13.29
12.63
6.35
Diluted EPS
9.54
8.46
8.06
11.16
11
10.24
9.17
12.75
13.08
12.45
6.32

J B Chemicals & Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
1,412.98
1,643.2
1,774.73
2,042.52
2,424.24
3,149.28
3,484.18
3,917.99
4,147.79
Other Income
37.11
41.44
50.67
112.38
39.23
9.94
37.27
38.32
60.15
Total Income
1,450.09
1,684.64
1,825.4
2,154.9
2,463.47
3,159.22
3,521.45
3,956.31
4,207.94
Expenses
1,195.67
1,337.36
1,407.15
1,482.11
1,880.79
2,453.53
2,587.29
2,886.15
3,067.54
Operating Profit
217.31
305.84
367.58
560.41
543.45
695.75
896.89
1,031.84
1,080.25
Operating Profit Margin %
15.38%
18.61%
20.71%
27.44%
22.42%
22.09%
25.74%
26.34%
26.04%
Profit Before Interest, Tax and Depreciation
254.42
347.28
418.24
672.79
582.68
705.69
934.16
1,070.16
1,140.4
Interest
3.49
4.65
3.03
7.24
5.12
36.05
44.33
11.73
5.57
Depreciation
56.97
55.64
66.32
68.67
72.66
114.41
138.32
171.04
182.5
Profit Before Tax
193.96
286.99
348.89
596.88
504.9
555.23
751.51
887.39
952.33
Tax Paid
55.23
93.02
76.5
148.36
118.86
145.23
198.88
227.81
242.86
Profit After Tax
138.72
193.97
272.39
448.52
386.04
410
552.63
659.58
709.47
Total Net profit including share of profit / Loss from associate company
138.72
193.97
272.39
448.52
386.04
410
552.63
659.58
709.47
EPS
16.48
23.54
34.2
57.96
49.86
53
35.66
42.45
45.16
Actual EPS
16.48
23.54
34.2
57.96
49.86
53
35.66
42.45
45.16
Adjusted EPS
8.24
11.77
17.1
28.98
24.93
26.5
35.66
42.45
45.16
Diluted EPS
16.48
23.54
34.2
57.96
49.86
52.34
34.85
41.56
44.45

J B Chemicals & Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
140.41
201.13
122.92
194.33
275.75
314.78
170.13
625.61
800.61
902.45
703.92
Cash Flow from Investing Activities
-25.91
-45.31
-20.68
-27.69
23.91
-230.63
2.33
-961.77
-403.85
-295.9
-585.73
Cash Flow from Financing Activities
-99.62
-183.84
-59.53
-155.74
-306.06
-87.43
-138.39
362.12
-385.49
-579.68
-123.09
Net Cash Flow
14.88
-28.02
42.72
10.9
-6.39
-3.28
34.07
20.39
11.28
26.88
-4.91

J B Chemicals & Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Jan 2026
Mar 2026
Promoters
53.86%
53.83%
53.78%
53.77%
53.74%
53.66%
47.84%
47.73%
47.56%
47.55%
48.78%
48.8%
DII
18.58%
17.97%
18.38%
17.62%
16.81%
16.41%
18.72%
19.63%
22.83%
23.36%
22.71%
21.38%
FII
10.05%
0%
11.06%
12.17%
13.63%
14.64%
18.3%
17.77%
15.3%
14.88%
14.56%
16.33%
Government
0%
0%
0.01%
0%
0.01%
0%
0%
0%
0%
0%
0%
0%
Public
17.51%
17.28%
16.78%
16.43%
15.81%
15.29%
15.14%
14.88%
14.3%
14.21%
13.95%
13.48%
Total Outstanding Shares
15,49,55,510
15,50,44,160
15,51,94,800
15,52,13,058
15,53,14,408
15,55,48,728
15,56,77,208
15,60,58,924
15,65,96,239
15,66,50,956
16,04,35,056
16,05,58,706
Total Shareholders
60,817
63,230
63,892
66,953
62,743
62,081
63,948
70,064
71,957
69,338
68,966
74,043

Mutual Funds that own J B Chemicals & Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in J B Chemicals & Pharmaceuticals.

J B Chemicals & Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of J B Chemicals & Pharmaceuticals.

  • J B Chemicals & Pharmaceuticals Ltd Earnings Results

    J B Chemicals & Pharmaceuticals Ltd’s net profit fell -30.42% since last year same period to ₹101.37Cr in the Q4 2025-2026. On a quarterly growth basis, J B Chemicals & Pharmaceuticals Ltd has generated -48.77% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • J B Chemicals & Pharmaceuticals Ltd Dividends May,2026

    In the quarter ending March 2026, J B Chemicals & Pharmaceuticals Ltd has declared dividend of ₹9.30 per share on 11 May 2026 - translating a dividend yield of 1.19%.

    Read More about Dividends

Indices Featuring J B Chemicals & Pharmaceuticals Stock

Check stock indices that include J B Chemicals & Pharmaceuticals.

S&P BSE SmallCap Select

₹8,776.32

89.17 (1.03%)

S&P BSE 250 SmallCap

₹7,153.51

84.85 (1.20%)

NIFTY PHARMA

₹25,674.10

17.85 (0.07%)

Nifty Smallcap 250

₹18,118.90

243.20 (1.36%)

Nifty MidSmallcap 400

₹21,331.15

286.20 (1.36%)

Nifty 500

₹23,348.40

267.25 (1.16%)

BSE 500

₹36,506.10

419.55 (1.16%)

BSE Healthcare

₹49,941.13

142.37 (0.29%)

S&P BSE 400 MidSmallCap

₹12,718.47

167.45 (1.33%)

Insights on J B Chemicals & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, JBCHEPHARM stock has moved up by 51.4%

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 48.78% to 48.80% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 14.56% to 16.33% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 19.22% to 19.00% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 207.82 Cr → 101.37 Cr (in ₹), with an average decrease of 26.8% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 13.95% to 13.48% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 1.10K Cr → 916.21 Cr (in ₹), with an average decrease of 5.9% per quarter

About J B Chemicals & Pharmaceuticals Ltd

J B Chemicals Pharmaceuticals, founded in 1976 in Maharastra, is a global player in pharmaceutical manufacturing. It manufactures and markets a wide range of pharmaceutical formulations, herbal remedies, APIs, and agro-based products. It has subsidiaries in India and other countries and has been awarded the Certificate of Suitability to European Pharmacopoeia Monograph for Nifedipine EP from the European Directorate for Quality Medicines. It launched new products in the global market to expand its product portfolio and received approval from TGA Australia, USFDA, MCC South Africa, INVIMA Colombia, and MHRA UK. The company received the 'Most Trustworthy European Brand' by Readers Digest in cold and cough segment for the fourth consecutive year in 2003-04. It diverted into the contrast media products market during 2004-05 and entered agreements with PharmaaCare Pharmaceuticals and Ranbaxy Group for developing and marketing niche products in respective markets. It has undergone several mergers and diversifications in-order to increase its product range and profitability. More recently, it acquired a portfolio of brands from Sanzyme Private Limited and Azmarda brand from Novartis AG Switzerland. Thus, J B Chemicals Pharmaceuticals is well positioned to grow and progress further in the global pharmaceutical market.

Revenue: ₹904.23Cr as on March 2026 (Q4 FY26)
Net Profit: ₹101.37Cr as on March 2026 (Q4 FY26)
Listing date: 02 Feb, 1995
Chairperson Name: Ranjit Shahani.
OrganisationJ B Chemicals & Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEORanjit Shahani.
E-voting on sharesClick here to vote

FAQs

What is J B Chemicals & Pharmaceuticals share price today?

J B Chemicals & Pharmaceuticals share price today stands at ₹2435.5 as on at the close of the market. J B Chemicals & Pharmaceuticals share today touched a day high of ₹2444.8 and a low of ₹2386.8.

What is the 52 week high and 52 week low range for J B Chemicals & Pharmaceuticals share?

J B Chemicals & Pharmaceuticals touched a 52 week high of ₹2467.7 and a 52 week low of ₹1603.5. J B Chemicals & Pharmaceuticals share price today i.e. is closed at ₹2435.5, which is -1.30% down from its 52 week high and 51.89% up from its 52 week low.

What is J B Chemicals & Pharmaceuticals's market capitalisation today?

J B Chemicals & Pharmaceuticals market capitalisation is ₹39,248.58 Cr as on .

How to buy J B Chemicals & Pharmaceuticals shares?

To buy J B Chemicals & Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for JBCHEPHARM or J B Chemicals & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in J B Chemicals & Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is J B Chemicals & Pharmaceuticals trading volume today?

J B Chemicals & Pharmaceuticals trading volume is 4.12L as on . This means that 4.12L shares of J B Chemicals & Pharmaceuticals were bought and sold on the stock market during today's trading session.